<DOC>
	<DOCNO>NCT02039440</DOCNO>
	<brief_summary>The purpose study determine whether persist antibody Japanese Encephalitis 6 year last vaccination IXIARO ( R ) adapt confirm mathematical model accordingly .</brief_summary>
	<brief_title>6-year Antibody Check After Third Vaccination Against Japanese Encephalitis</brief_title>
	<detailed_description>Japanese Encephalitis ( JE ) potentially devastate mosquito-borne viral disease . The JE virus ( JEV ) , Flavivirus , endemic many region Asia , JE primarily pediatric disease endemic region , traveler non-endemic region Asia usually na√Øve virus may risk contract JE age . The present study aim investigate antibody titer approximately 6 year third dose JE vaccine ( JE-VC ) , cohort participant earlier booster dose trial , strengthen statistical model duration protection booster .</detailed_description>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Encephalomyelitis , Acute Disseminated</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Subjects receive booster dose JEVC study IC51311 Subjects willing give write informed consent participate trial Subjects receive dose Japanese Encephalitis Vaccine since study IC51311 Severe immunosuppression ( result medical condition medication ) since study IC51311 , history radiation therapy cytostatic therapy simultaneous participation another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>